300 companies
TIL
Instil Bio Inc
instil bio is a cell therapy company developing tumor infiltrating lymphocytes (til) for the treatment of solid tumor cancers.
Texas
NASDAQ
INTS
Intensity Therapeutics Inc
intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments.
Connecticut
NASDAQ
INRX
Intrinsic Medicine, Inc.
Washington
NASDAQ
IVVD
Invivyd Inc
adagio is developing best-in-class antibodies that can broadly neutralize sars-cov-2, sars-cov-1 and additional potentially emergent coronaviruses.
Massachusetts
NASDAQ
IZTC
Invizyne Technologies Inc
NASDAQ
IOVA
Iovance Biotherapeutics Inc
iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr.
California
NASDAQ
LIMN
Iris Parent Holding Corp.
JSPR
Jasper Therapeutics Inc
jasper therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.
California
NASDAQ
JNCE
Jounce Therapeutics Inc
Jounce Therapeutics, Inc.
Massachusetts
NASDAQ
KLDO
Kaleido Biosciences, Inc.
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health.
Massachusetts
NASDAQ
Kenneth J Novack
KRBP
Kiromic Biopharma, Inc.
kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules.
Texas
NASDAQ
KOD
Kodiak Sciences Inc
about kodiak kodiak is a high-science retinal medicines development company.
California
NASDAQ
KRYS
Krystal Biotech Inc
krystal biotech, inc.
Pennsylvania
NASDAQ
KYMR
Kymera Therapeutics Inc
kymera therapeutics is pioneering a transformative new approach to treating previously untreatable diseases.
Massachusetts
NASDAQ
KYTX
Kyverna Therapeutics Inc.
California
NASDAQ
LENZ
LENZ Therapeutics Inc.
graphite bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases.
California
NASDAQ
LJPC
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Company is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases.
Massachusetts
NASDAQ
LADX
LadRx Corp
LadRx Corporation is a biopharmaceutical research and development company specializing in oncology.
California
OTC
LXEO
Lexeo Therapeutics Inc.
Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease are treated.
New York
NASDAQ